Drug Channels

SEPTEMBER 29, 2024

Informa Connect's Copay, Reimbursement and Access Congress November 18-20, 2024 | Hilton Penn’s Landing in Philadelphia, PA Drug Channels readers save 10% with code USAVE24 * The access and affordability landscape is undergoing a seismic shift. Evolving legislation, disruptive market forces and the ever-growing complexities of cost sharing programs threaten patient adherence and commercialization strategies.

Marketing 52

Marketing Drugs 52

Perficient: Drug Development

SEPTEMBER 29, 2024

Part 2 Hello Trailblazers! In Salesforce Lightning Web Components (LWC), the Navigation Service plays a crucial role in creating a seamless user experience by enabling easy, programmatic navigation between different pages, records, or external links. In the previous Part 1 of this blog we saw the basics of the Navigation Services and how to navigate a user to the record page.

52

52

Drugs.com

SEPTEMBER 29, 2024

SUNDAY, Sept. 29, 2024 -- A tumble, a tackle: Anything can bring on a sidelining sports injury. Now, four experts in such injuries at Penn State Health give advice on recovery and when it's okay to return to play.AC shoulder sprainsThis happens.

52

52

Perficient: Drug Development

SEPTEMBER 29, 2024

Part 1 Hello Trailblazers! Lightning Web Components (LWC) has transformed how developers create modern and efficient applications within the Salesforce platform. One of the key functionalities that enhances user experience in LWC is the Navigation Service. This service allows developers to navigate between different components, pages, or external URLs with ease.

52

52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Codon

SEPTEMBER 29, 2024

2024 Statistical models of organisms have existed for decades. The earliest ones relied on simple linear regression and attempted to correlate genetic variations with observable traits or disease risks — such as drug metabolization rates or cancer susceptibility. As computational power increased and machine learning techniques advanced, the models’ sophistication grew.

Engineering 125

Engineering Virus DNA Therapies 125

New Drug Approvals

SEPTEMBER 29, 2024

ATUZAGINSTAT, COR388 cas 2211981-76-7 Cyclopentanecarboxamide, N -[(1 S )-5-amino-1-[2-(2,3,6-trifluorophenoxy)acetyl]pentyl]- Cyclopentanecarboxamide, n-((1s)-5-amino-1-(2-(2,3,6-trifluorophenoxy)acetyl)pentyl)-N-((3s)-7-amino-2-oxo-1-(2,3,6- trifluorophenoxy)heptan-3-yl)cyclopentanecarboxamide C 19 H 25 F 3 N 2 O 3 386.415 UNII-DGN7ROZ8EN Originator Cortexyme Developer Quince Therapeutics Class Anti-inflammatories; Antibacterials; Antidementias; Antineoplastics; Antiparkinsonians; Neuroprotect

Small Molecule 62

Small Molecule DNA Disease Trials 62